Inventor · disambiguated record
Ligang Qian
Also filed as: QIAN LIGANG
12 granted patents·1 pending application·346 citations·filing 2000–2020
92Inventor score
Top patents by PatentIndex Score
13 records- 0197US6982265B1Pyrrolotriazine inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jan 3, 2006·117 cites·9 claims
- 0296US7244733B2Pyrrolotriazine inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jul 17, 2007·40 cites·2 claims
- 0396US6869952B2Pyrrolo[2,1-f][1,2,4]triazine inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Mar 22, 2005·92 cites·7 claims
- 0491US7265113B2Inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 4, 2007·12 cites·4 claims
- 0590US7521450B2Inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Apr 21, 2009·11 cites·5 claims
- 0690US7112675B2Pyrrolotriazine inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 26, 2006·12 cites·5 claims
- 0789US7102002B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 5, 2006·17 cites·6 claims
- 0887US6933386B2Process for preparing certain pyrrolotriazine compoundsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 23, 2005·37 cites·10 claims
- 0980US7820814B2Inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 26, 2010·2 cites·4 claims
- 1073US7084160B2Heterocyclic inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 1, 2006·6 cites·4 claims
- 1156US7547711B2Heterocyclic inhibitors of kinasesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 16, 2009·0 cites·2 claims
- 1252US2022380310A1P2x7r antagonistsQIAN LIGANG·Filed 2020·Application pending·0 cites
- 1343US11553713B2Polyalcohol, carbohydrate, nucleobase and nucleotide compositions and uses thereofCHUNBO ZHANG·Filed 2016·Granted Jan 17, 2023·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Ligang Qian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →